Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double‐blind placebo‐controlled clinical trial
In a small, double-blind, placebo-controlled trial of Japanese adults aged 50–80 with mild cognitive impairment, 30 people were randomly assigned to take Yamabushitake (an edible mushroom) or placebo for 16 weeks. The mushroom group took four 250 mg tablets three times a day and showed higher scores on a cognitive…
